Market Overview

Wunderlich Securities Maintains Hold Rating on Heartware International


A report from Wunderlich Securities reiterates its Hold rating and $80 price target on Heartware International (NASDAQ: HTWR).

The report states, “…it now looks clear that Heartware's HVAD will not be reviewed by the FDA's Circulatory System Devices Panel meeting in early December. As a result, FDA approval of the HVAD will now almost certainly be delayed beyond the prevailing Street consensus of early 2012. But we expect the delay could be modest, with a panel meeting possible as soon as either January or February. We reiterate our Hold rating, but we believe an over-reaction to this news could result in an attractive buying opportunity for investors”.

HTWR closed yesterday at $62.04.

Posted-In: Wunderlich SecuritiesAnalyst Color Reiteration Analyst Ratings


Related Articles (HTWR)

View Comments and Join the Discussion!

Latest Ratings

ARAVH.C. WainwrightReiterates31.0
KMPHH.C. WainwrightReiterates2.5
HASusquehannaInitiates Coverage On27.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Wunderlich Securities Maintains Hold Rating and $32 PT on New Oriental Education & Technology Group

Wunderlich Initiates Fortinet at Hold, $20 PT